See also this year's filing and all EDGAR filings for this company.
PDF Report 0001439725_2023_Biodesix_INC.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.2987062002747626, 'aggregate_val': 92906000, 'exp_sum': 132478000, 'exp_to_value': {'IntangibleAssets': 24828000, 'AssetsNonCurrent': 39572000, 'AssetsCurrent': 53334000, 'PropertyPlantAndEquipment': 5848000, 'remainder_Assets': 8896000}} |
Graph
Absolute values for 0001439725, Biodesix INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 24,828,000 |
| 1 | AssetsNonCurrent | 39,572,000 |
| 2 | AssetsCurrent | 53,334,000 |
| 3 | PropertyPlantAndEquipment | 5,848,000 |
| 4 | remainder_Assets | -30,676,000 |
| 5 | LongTermLiabilities | 49,461,000 |
| 6 | LiabilitiesCurrent | 22,839,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 61,462,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 13,102,000 |
| 16 | remainder_Expenses | 14,235,000 |
| 17 | remainder_Revenues | 38,212,000 |
| 18 | remainder_NetIncome | -14,860,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 92,906,000 |
| 1 | Liabilities | 72,300,000 |
| 2 | Expenses | 88,799,000 |
| 3 | Revenues | 38,212,000 |
| 4 | StockholdersEquity | 20,606,000 |
| 5 | NetIncome | -65,447,000 |
| 6 | ComprehensiveNetIncome | -65,447,000 |
| 7 | BaseVar | 153,538,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.431 |
| 9 | EconomicCapitalRatio | 0.841 |
Edgar->Model Mapping
Feature Distribution
Change over Time
